Medicine
Latuda 20 mg tablet
Latuda 20 mg tablet is a prescription medicine containing Lurasidone for oral use, marketed by Sumitomo Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store LATUDA tablets at 25°C (77°F), excursions permitted to 15° - 30°C (59° -…
Key facts
- Active ingredient (INN)
- Lurasidone
- Brand
- Latuda
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 4 blister pack, 10 blister pack, 30 tablets and 2 more
- Marketing authorisation holder
- Sumitomo Pharma
- Manufacturer
- Sumitomo Pharma
- Origin register
- US FDA, United States
- Storage
- Store LATUDA tablets at 25°C (77°F), excursions permitted to 15° - 30°C (59° - 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AE05 Lurasidone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 December 2011
- Identifiers
- RxCUI 1040031, 1040036, 1040041 +7DailyMed set ID afad3051-9df2-4c54-9684-e8262a133af8NDC 63402-302Application NDA200603
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 blister pack in 1 carton / 7 tablet, film coated in 1 blister pack | 63402-302-04 | Sumitomo Pharma | 7 December 2011 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 63402-302-10 | Sumitomo Pharma | 7 December 2011 |
| 30 tablet, film coated in 1 bottle | 63402-302-30 | Sumitomo Pharma | 7 December 2011 |
| 500 tablet, film coated in 1 bottle | 63402-302-50 | Sumitomo Pharma | 7 December 2011 |
| 90 tablet, film coated in 1 bottle | 63402-302-90 | Sumitomo Pharma | 7 December 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lurasidone 20 mg tablet.
Other strengths and forms of Lurasidone
Clinical summary
Lurasidone is an atypical antipsychotic indicated for treatment of adult and adolescent patients (13 to 17 years) with schizophrenia. It is available as tablets for oral use. MedsAcross supplies Lurasidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LurasidoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Latuda prescribing information (Sumitomo Pharma) · U.S. National Library of Medicine, DailyMed
- Latuda: European public assessment report (EPAR) · European Medicines Agency
Need Latuda 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.